611 related articles for article (PubMed ID: 22685115)
1. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiac myocyte CXCR4 expression in development and left ventricular remodeling after acute myocardial infarction.
Agarwal U; Ghalayini W; Dong F; Weber K; Zou YR; Rabbany SY; Rafii S; Penn MS
Circ Res; 2010 Sep; 107(5):667-76. PubMed ID: 20634485
[TBL] [Abstract][Full Text] [Related]
3. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.
Zhang M; Mal N; Kiedrowski M; Chacko M; Askari AT; Popovic ZB; Koc ON; Penn MS
FASEB J; 2007 Oct; 21(12):3197-207. PubMed ID: 17496162
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
Noiseux N; Gnecchi M; Lopez-Ilasaca M; Zhang L; Solomon SD; Deb A; Dzau VJ; Pratt RE
Mol Ther; 2006 Dec; 14(6):840-50. PubMed ID: 16965940
[TBL] [Abstract][Full Text] [Related]
6. Role of SDF-1:CXCR4 in Impaired Post-Myocardial Infarction Cardiac Repair in Diabetes.
Mayorga ME; Kiedrowski M; McCallinhart P; Forudi F; Ockunzzi J; Weber K; Chilian W; Penn MS; Dong F
Stem Cells Transl Med; 2018 Jan; 7(1):115-124. PubMed ID: 29119710
[TBL] [Abstract][Full Text] [Related]
7. CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
Bonaros N; Sondermeijer H; Schuster M; Rauf R; Wang SF; Seki T; Skerrett D; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1044-53. PubMed ID: 18954648
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
Cheng Y; Hu R; Lv L; Ling L; Jiang S
J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction.
Dubois C; Liu X; Claus P; Marsboom G; Pokreisz P; Vandenwijngaert S; Dépelteau H; Streb W; Chaothawee L; Maes F; Gheysens O; Debyser Z; Gillijns H; Pellens M; Vandendriessche T; Chuah M; Collen D; Verbeken E; Belmans A; Van de Werf F; Bogaert J; Janssens S
J Am Coll Cardiol; 2010 May; 55(20):2232-43. PubMed ID: 20466204
[TBL] [Abstract][Full Text] [Related]
12. Paracrine effect of CXCR4-overexpressing mesenchymal stem cells on ischemic heart injury.
Wu SZ; Li YL; Huang W; Cai WF; Liang J; Paul C; Jiang L; Wu ZC; Xu M; Zhu P; Wang Y
Cell Biochem Funct; 2017 Mar; 35(2):113-123. PubMed ID: 28233339
[TBL] [Abstract][Full Text] [Related]
13. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction.
Liehn EA; Tuchscheerer N; Kanzler I; Drechsler M; Fraemohs L; Schuh A; Koenen RR; Zander S; Soehnlein O; Hristov M; Grigorescu G; Urs AO; Leabu M; Bucur I; Merx MW; Zernecke A; Ehling J; Gremse F; Lammers T; Kiessling F; Bernhagen J; Schober A; Weber C
J Am Coll Cardiol; 2011 Nov; 58(23):2415-23. PubMed ID: 22115649
[TBL] [Abstract][Full Text] [Related]
14. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
15. Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts.
Zhang D; Huang W; Dai B; Zhao T; Ashraf A; Millard RW; Ashraf M; Wang Y
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1339-47. PubMed ID: 20802132
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9.
Huang W; Wang T; Zhang D; Zhao T; Dai B; Ashraf A; Wang X; Xu M; Millard RW; Fan GC; Ashraf M; Yu XY; Wang Y
Stem Cells Dev; 2012 Mar; 21(5):778-89. PubMed ID: 21671800
[TBL] [Abstract][Full Text] [Related]
17. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.
Boomsma RA; Swaminathan PD; Geenen DL
Int J Cardiol; 2007 Oct; 122(1):17-28. PubMed ID: 17187879
[TBL] [Abstract][Full Text] [Related]
18. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
[TBL] [Abstract][Full Text] [Related]
19. Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.
Lu W; Xie Z; Tang Y; Bai L; Yao Y; Fu C; Ma G
Theranostics; 2015; 5(10):1068-82. PubMed ID: 26199646
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.
Tang YL; Zhu W; Cheng M; Chen L; Zhang J; Sun T; Kishore R; Phillips MI; Losordo DW; Qin G
Circ Res; 2009 May; 104(10):1209-16. PubMed ID: 19407239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
